Skip to main content

Table 3 Drug likeness/pharmacophore and ADMET profile of screened antiviral flavonoids (phytochemicals) along with drugs used as control for docking against Mpro/3CLpro, PLpro and ACE2 of COVID-19

From: Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: an in silico molecular modeling approach in battling the COVID-19 outbreak

Name

Drug likeness/pharmacophore features

ADMET properties

MWa (Da)

Log Pb

Log Sc

HBAd

HBDe

TPSAf2)

Molar refractivity

Drug likeness

Violation of Lipinski’s rule of five

BBBg permeability

HIAh

Caco-2 permeability

AMES toxicity

Carcinogenic

Mutagenic

Tumorigenic

Irritant

Reproductive effect

C1

270.05

1.14

− 2.86

5

3

86.99

73.99

0.28

No

Yes

Yes

Yes

No

No

Yes

No

No

None

C2*

270.05

2.63

− 2.86

5

3

86.99

73.99

0.28

No

No

Yes

No

No

No

No

No

No

None

C3*

286.05

1.49

− 2.86

6

4

107.22

76.01

0.28

No

No

Yes

No

No

No

No

No

No

None

C4

448.1

− 0.36

− 1.97

11

8

197.37

108.63

− 2.0

Yes

No

Yes

No

Yes

No

Yes

No

No

None

C5

432.11

− 0.71

− 2.27

10

7

177.14

106.61

− 2.0

Yes

No

Yes

No

Yes

No

Yes

No

No

None

C6

360.08

2.29

− 2.96

8

3

114.68

93.47

− 0.16

No

No

Yes

Yes

No

No

Yes

No

No

None

C7

460.1

0.94

− 3.04

11

5

172.21

111.19

0.5

Yes

No

Yes

No

No

No

Yes

Yes

No

None

C8*

254.06

1.85

− 3.15

4

2

66.76

71.97

0.28

No

Yes

Yes

Yes

No

No

No

No

No

None

C9

372.12

2.58

− 3.83

7

0

72.45

100.38

0.36

No

Yes

Yes

Yes

No

No

Yes

Yes

No

None

C10

284.07

2.09

− 3.17

5

2

75.99

78.46

0.4

No

No

Yes

Yes

No

No

Yes

No

No

None

C11

302.04

1.83

− 2.49

7

5

127.45

78.03

− 0.08

No

No

Yes

No

No

No

Yes

Yes

No

None

C12

286.05

1.49

− 2.79

6

4

107.22

76.01

− 0.08

No

Yes

Yes

No

No

No

Yes

No

No

None

C13

610.15

− 0.74

− 2.4

16

10

265.52

141.4

1.93

Yes

No

Yes

No

No

No

No

No

No

None

C14

286.05

1.92

− 2.79

6

4

107.22

76.01

− 0.08

No

Yes

Yes

No

No

No

Yes

No

No

None

C15

564.13

0.88

− 3.93

12

9

217.6

143.98

1.46

Yes

No

Yes

No

No

No

No

No

No

None

C16*

290.08

1.12

− 1.62

6

5

110.38

74.33

− 0.07

No

No

Yes

No

No

No

No

No

No

None

C17

318.04

2.18

− 2.19

8

6

147.68

80.06

− 0.08

Yes

No

Yes

No

No

No

Yes

No

No

None

C18*

300.06

1.38

− 2.91

6

3

96.22

80.48

− 0.11

No

No

Yes

Yes

No

No

No

No

No

None

C19

316.06

1.73

− 2.81

7

4

116.45

82.5

0.06

No

No

Yes

Yes

No

No

Yes

No

No

None

C20

270.05

2.2

− 3.08

5

3

86.99

73.99

− 0.08

No

Yes

Yes

No

No

No

Yes

No

No

None

C21

302.04

1.41

− 2.49

7

5

127.45

78.03

− 0.08

No

Yes

Yes

No

No

No

Yes

No

No

None

C22*

286.08

1.69

− 2.97

5

3

86.99

78.81

0.22

No

No

Yes

Yes

No

No

No

No

No

None

C23*

270.09

1.56

− 3.27

4

2

66.76

76.79

0.22

No

Yes

Yes

Yes

No

No

No

No

No

None

C24*

290.08

0.85

− 1.76

6

5

110.38

74.33

0.32

No

No

Yes

No

No

No

No

No

No

None

C25

458.08

2.98

− 2.16

11

8

197.37

112.06

− 0.33

Yes

No

Yes

No

No

No

No

No

No

None

C26

442.09

2.64

− 2.46

10

7

177.14

110.04

− 0.33

Yes

No

Yes

No

No

No

No

No

No

None

C27

306.07

1.2

− 1.47

7

6

130.61

76.36

0.32

Yes

No

Yes

No

No

No

No

No

No

None

C28

270.05

1.04

− 2.72

5

3

86.99

73.99

− 0.09

No

Yes

Yes

Yes

No

No

Yes

Yes

No

Yes

C29

284.07

1.36

− 3.04

5

2

75.99

78.46

0.04

No

No

Yes

Yes

No

No

No

No

No

Yes

C30

254.06

1.12

− 3.02

4

2

66.76

71.97

− 0.09

No

Yes

Yes

Yes

No

No

No

No

No

Yes

C31

416.11

− 0.72

− 2.44

9

6

156.91

104.59

− 2.4

Yes

No

Yes

No

Yes

No

No

No

No

Yes

C32

430.13

0.14

− 3.22

9

4

134.91

108.56

− 3.44

No

No

Yes

No

No

No

No

Yes

No

None

C33*

284.07

1.36

− 3.04

5

2

75.99

78.46

0.04

No

No

Yes

Yes

No

No

No

No

No

None

C34*

268.07

1.45

− 3.34

4

1

55.76

76.43

0.04

No

Yes

Yes

Yes

No

No

No

No

No

None

C35*

287.06

2.41

− 3.25

6

5

101.15

76.17

− 2.12

No

Yes

Yes

No

No

No

No

No

No

None

C36*

301.07

1.86

− 3.57

6

4

90.15

80.64

− 5.89

No

No

Yes

Yes

No

No

No

No

No

None

C37*

331.08

2.1

− 3.57

7

4

99.38

87.13

− 5.89

No

No

Yes

Yes

No

No

No

No

No

None

C38*

290.03

2.21

− 3.85

4

3

60.69

77.98

− 6.14

No

Yes

Yes

Yes

No

No

No

No

No

None

C39

338.02

2.83

− 2.96

7

6

121.38

84.05

− 6.14

Yes

Yes

Yes

No

No

No

No

No

No

None

C40*

288.06

1.14

− 2.34

6

4

107.22

73.59

− 0.22

No

No

Yes

No

No

No

No

No

No

None

C41*

302.08

1.03

− 2.66

6

3

96.22

78.06

− 0.09

No

No

Yes

Yes

No

No

No

No

No

None

C42*

272.07

0.79

− 2.64

5

3

86.99

71.57

− 0.22

No

Yes

Yes

Yes

No

No

No

No

No

None

C43*

324.14

2.49

− 3.86

4

2

66.76

93.27

− 0.34

No

No

Yes

Yes

No

No

No

No

No

None

Con-1

335.18

1.55

− 3.55

4

2

47.86

98.57

5.73

No

Yes

Yes

No

Yes

No

Yes

No

No

None

Con-2

602.33

0.34

− 4.99

14

4

211.13

150.43

− 21.38

Yes

No

Yes

No

No

No

No

Yes

Yes

Yes

Con-3

398.16

− 0.72

− 2.99

9

2

137.31

123.31

2.7

No

Yes

No

No

No

Yes

No

No

No

None

  1. *Indicates the flavonoids which passed all the following parameters
  2. aMolecular weight
  3. bPartition coefficient between n-octanol and water
  4. cWater solubility
  5. dHydrogen bond acceptor
  6. eHydrogen bond donor
  7. fTopological polar surface area
  8. gBlood Brain Barrier
  9. hHuman intestinal absorption